NO20045587L - Liposom vaksineformulering for finne-fisk - Google Patents
Liposom vaksineformulering for finne-fiskInfo
- Publication number
- NO20045587L NO20045587L NO20045587A NO20045587A NO20045587L NO 20045587 L NO20045587 L NO 20045587L NO 20045587 A NO20045587 A NO 20045587A NO 20045587 A NO20045587 A NO 20045587A NO 20045587 L NO20045587 L NO 20045587L
- Authority
- NO
- Norway
- Prior art keywords
- fish
- vaccines
- liposome
- vaccine formulation
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0233—Rickettsiales, e.g. Anaplasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/107—Vibrio
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0208—Specific bacteria not otherwise provided for
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Abstract
Det beskrives liposomvaksineformuleringer for fmne-fisk som omfatter antigenisk materiale avledet fra ett eller flere firm-fiskpatogener i assosiasjon med liposomer og som eventuelt inkluderer andre terapeutiske forbindelser. Vaksinene kan anvendes for immunisering og/eller for terapeutisk behandling av firme-fisk mot infeksiøse og parasittiske sykdommer. Vaksinene kan gi reduserte bivirkninger som mindre adhesjoner og pigmentering sammenlignet med oljebaserte vaksineformuleringer. Det besltrives videre fremgangsmåter for fremstilling og lagring av liposomvaksinene og metoder for adminisfrering av vaksineformuleringen til firme-fisk.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38502802P | 2002-05-31 | 2002-05-31 | |
PCT/CA2003/000768 WO2003101482A2 (en) | 2002-05-31 | 2003-05-30 | Liposome vaccine formulations for fin-fish |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20045587L true NO20045587L (no) | 2004-12-22 |
NO335784B1 NO335784B1 (no) | 2015-02-16 |
Family
ID=29712127
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20045587A NO335784B1 (no) | 2002-05-31 | 2004-12-22 | Liposomvaksine omfattende antigenisk materiale fra finne-fisk patogener. |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003229199A1 (no) |
NO (1) | NO335784B1 (no) |
WO (1) | WO2003101482A2 (no) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006010265A1 (en) | 2004-07-28 | 2006-02-02 | National Research Council Of Canada | Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof |
CN1276076C (zh) * | 2004-12-14 | 2006-09-20 | 华东理工大学 | 一种鳗弧菌野生毒株的无标记基因缺失减毒突变株及其应用 |
WO2007091580A1 (ja) * | 2006-02-07 | 2007-08-16 | Nippon Biologicals, Inc. | 新規ワクチン担体 |
JP2010514412A (ja) | 2006-12-22 | 2010-05-06 | ソリューシオネス バイオテクノロジカス イノヴァシオン リミターダ | Dna魚ワクチン |
ES2321789B1 (es) * | 2007-03-02 | 2010-03-15 | Instituto Nacional De Investigacion Y Tecnologia Agraria Y Alimentaria (Inia) | Utilizacion del vector pil8+ de trucha como inmunoestimulante o adyuvante para vacunas adn en peces. |
US8343505B2 (en) * | 2007-12-04 | 2013-01-01 | Schweitzer Co., Ltd. | Subunit vaccine for aquaculture |
NO333242B1 (no) * | 2008-02-08 | 2013-04-15 | Pharmaq As | Sammensetning, medisinsk anvendelse og fremgangsmate som omfatter salmonid alfavirus |
CN107099496B (zh) * | 2017-04-25 | 2021-04-13 | 中国农业科学院哈尔滨兽医研究所 | 融合表达鸡传染性法氏囊病毒vp2蛋白和沙门菌属外膜蛋白的重组乳酸菌菌株及其用途 |
NO20200827A1 (en) * | 2017-12-26 | 2020-07-14 | Univ Chile | Vaccine formulation for fish based on lipid nanovesicles,particularly a proteoliposome or cochleate, with activity against the salmonid rickettsial syndrome (srs) |
CN111018955B (zh) * | 2020-01-06 | 2021-10-26 | 济南大学 | 一种抑制病毒基因组rna复制的多肽 |
KR102458429B1 (ko) * | 2021-03-18 | 2022-10-26 | 대한민국 | 바이러스성 출혈성 패혈증 예방을 위한 어류 경구백신용 리포좀 및 이의 제조방법 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2356452A1 (en) * | 1998-12-22 | 2000-06-29 | Robert Brown | Compositions and methods for reducing or preventing fertilization in fish and birds |
-
2003
- 2003-05-30 WO PCT/CA2003/000768 patent/WO2003101482A2/en not_active Application Discontinuation
- 2003-05-30 AU AU2003229199A patent/AU2003229199A1/en not_active Abandoned
-
2004
- 2004-12-22 NO NO20045587A patent/NO335784B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2003229199A8 (en) | 2003-12-19 |
NO335784B1 (no) | 2015-02-16 |
AU2003229199A1 (en) | 2003-12-19 |
WO2003101482A3 (en) | 2004-02-05 |
WO2003101482A2 (en) | 2003-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20040258L (no) | Preparat for behandling av negleinfeksjoner med nitrogenoksid | |
NO20015073L (no) | Vaksiner | |
WO2007095976A3 (de) | Adjuvanz in form einer lipid-modifizierten nukleinsäure | |
WO2005116270A3 (en) | Influenza virus vaccine composition and method of use | |
NO20045587L (no) | Liposom vaksineformulering for finne-fisk | |
CY1110332T1 (el) | Παραγωγα βενζιμιδαζολης, συνθεσεις που τα περιεχουν, παρασκευη αυτων και χρηση τους | |
NO20076613L (no) | Farmasoytiske formuleringer og anvendelse derav | |
CY1117129T1 (el) | Συγκεκριμενες φωσφορικες ενωσεις αμυναλκιλικου γλυκοζαμινιδιου και η χρηση τους | |
CY1105221T1 (el) | Ιατρικη χρηση θυρεοειδομιμητικων ενωσεων για την θepαπευτικη αγωγη της τριχοπτωσης και φαρμακευτικες συνθεσεις | |
CY1117237T1 (el) | Συνθεσεις σταθερων τιακουμυκινων | |
MA32819B1 (fr) | Vaccin combine notamment contre la coqueluche acellulaire | |
WO2014205199A3 (en) | Compositions and methods for potentiating immune response, enhancing immunotherapy, and increasing vaccine potency | |
DE60331412D1 (de) | Hiv-vakzine und anwendungsverfahren | |
CY1120793T1 (el) | Μεθοδοι θεραπευτικης αγωγης παθησεων που αφορουν μαλλια | |
EA200801411A1 (ru) | Новые адъюванты на основе конъюгатов и производных бис-ацилоксипропилцистеина и их применения в фармацевтических композициях | |
CY1112867T1 (el) | Πεπτιδια επιτοπων που προερχονται απο τον υποδοχεα 1 του αγγειακου ενδοθηλιακου αυξητικου παραγοντα και εμβολια περιεχοντας αυτα τα πεπτιδια | |
BRPI0418157A (pt) | terapêutica de tumores alogênicos | |
ATE460943T1 (de) | Therapeutische mittel als antikrebs impfstoffadjuvantien und deren therapeutische verfahren | |
CY1109233T1 (el) | Προφυλακτικη και θεραπευτικη χρηση υδροξυστεροειδων | |
DE60336588D1 (de) | Verbesserte anthraximpfstoffe und abgabeverfahren | |
NO20062469L (no) | Streptococcus phocae vaksine | |
MX344544B (es) | Vacuna para paludismo en etapa sanguinea. | |
EA201792237A1 (ru) | Фармацевтические составы | |
ECSP056190A (es) | Compuestos utiles en la terapia de la enfermedad de alzheimer y formulaciones que los contienen | |
DE60330004D1 (de) | Impfung mit immunisolierten und einen immunomodulator produzierenden zellen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CREP | Change of representative |
Representative=s name: PLOUGMANN & VINGTOFT POSTBOKS 1003 SENTRUM OSLO, 0 |
|
CREP | Change of representative |
Representative=s name: ONSAGERS AS, POSTBOKS 1813 VIKA, 0123 OSLO, NORGE |
|
MK1K | Patent expired |